Top

Published in:

01-04-2017 | Case report

Mycophenolate mofetil

Various toxicities during off label use: 3 case reports

Published in: Reactions Weekly | Issue 1/2017

Excerpt

A prospective observational study of 24 patients, described three patients [ages and sexes not stated], who developed dyspepsia with abdominal pain (one patient), mild increase in creatinine levels (one patient) or fatigue (one patient) during off label treatment with mycophenolate mofetil [routes, durations of treatment to reactions onsets and outcomes not stated]. …

Macaluso FS, et al. Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-alpha inhibitors and conventional immunosuppressants. Digestive and Liver Disease 49: 157-162, No. 2, Feb 2017. Available from: URL: http://doi.org/10.1016/j.dld.2016.10.001 - ItalyCrossRefPubMed

Title: Mycophenolate mofetil
Various toxicities during off label use: 3 case reports
Publication date: 01-04-2017
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2017
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-017-28293-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Mycophenolate mofetil

Various toxicities during off label use: 3 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

Botulinum toxin A

Warfarin

Desflurane/sevoflurane

Mercaptopurine

Infliximab

Aripiprazole